Sign In
Buy SAVA
$1.96
+0 (+0%)
At Close: Jun 03, 2026
Why Cassava Sciences Stock Zoomed 21% Higher This Week
06:06pm, Friday, 15'th Dec 2023
The biotech has declared a fresh dividend. The payout is rather atypical -- it's in the form of common stock warrants.
Why Is Cassava Sciences (SAVA) Stock Up 15% Today?
02:02pm, Tuesday, 12'th Dec 2023
Shares of pharmaceutical specialist Cassava Sciences (NASDAQ: SAVA ) soared earlier Tuesday before giving up most of the gains. Nevertheless, investor enthusiasm spiked over management's decision to i
Why Cassava Sciences Stock Soared Today
07:31pm, Friday, 08'th Dec 2023
The biotech significantly modified its board of directors. Two of those incoming directors have extensive experience in the healthcare field; the other comes from the security sphere.
Alzheimer's Disease Drug Development: Another Lost Year
03:58am, Tuesday, 05'th Dec 2023
Investing in most current Alzheimer's drug companies is not recommended because they are not likely to modify the disease. Compounds that inhibit oxidative stress may only slow down the progression of
Cassava Sciences: Likely Potential Opportunity From Phase 3 Readout Next Year
03:15am, Monday, 20'th Nov 2023
Cassava Sciences is a biotech company focused on developing treatments for Alzheimer's disease with its lead drug candidate, Simufilam. The company has faced allegations of data manipulation and misco
7 High-Risk, High-Reward Stocks for the Extreme Contrarian
09:53pm, Tuesday, 14'th Nov 2023
Although the general concept of stock picks for contrarian investors may be universally appealing, when it comes to the most extreme examples, most investors should probably stay away. Basically, whil
1 Big Red Flag to Fear When a Stock Is Down
08:15am, Tuesday, 31'st Oct 2023
Stocks often lose much of their value as a result of controversies. Cassava Sciences is facing a raft of serious allegations from numerous parties.
Cassava Sciences: My Bullish Take On Biomarkers And CTAD Data
03:30am, Monday, 30'th Oct 2023
Cassava Sciences' stock is highly disputed due to conflicting opinions on the science behind its drug candidate, but outside research supports its apparent drug effect. Biomarkers show strong reductio
7 Stocks That Are Heading for a Train Wreck
09:59am, Thursday, 19'th Oct 2023
One of the big slogans favored by CNBC pundit Jim Cramer is, “There's always a bull market somewhere.” I believe that's true.
SAVA Stock Continues to Plunge on Misconduct Allegations
05:26pm, Monday, 16'th Oct 2023
Big problems appear to be getting worse for Cassava Sciences (NASDAQ: SAVA ). The clinical-stage biotech company is a former favorite among retail investors.
SAVA Stock Alert: Cassava Sciences Addresses Leaked Report
11:21am, Friday, 13'th Oct 2023
Cassava Sciences (NASDAQ: SAVA ) stock was hit hard after the market close yesterday following the publication of a Science article that released the details on a report published by the City Univers
Cassava Sciences slumps after leaked report claims 'egregious misconduct' over Alzheimer's drug
10:06am, Friday, 13'th Oct 2023
Cassava Sciences Inc has denied data manipulation after a probe into conduct over its Alzheimer's drug research was leaked yesterday, sending its shares spiralling lower. Shares of Cassav were down
Cassava shares plummet after investigation accuses researcher of ‘egregious misconduct'
08:39am, Friday, 13'th Oct 2023
Shares of biotech company Cassava Sciences Inc. were slammed in extended trading Thursday, after the publication Science reported that an investigation accused a neuroscientist who often collaborated
Cassava Sciences slumps after leak claims “egregious misconduct”
05:29am, Friday, 13'th Oct 2023
Cassava Sciences Inc has denied data manipulation after a probe into conduct over its Alzheimer's drug research was leaked yesterday, sending its shares into a spiral. The company's share price on
Cassava Sciences: Unconvincing Open Label Studies, Upcoming Phase 3, Risky AD Bet
09:47am, Wednesday, 11'th Oct 2023
The Alzheimer's Disease space is highly volatile, with stock prices reacting to positive or negative data from other companies in the sector. Cassava Sciences, Inc. experienced a correction after init
